# Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients

> **NCT03899389** · — · COMPLETED · sponsor: **Gdansk University of Physical Education and Sport** · enrollment: 600 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DIAGNOSTIC_TEST:** plasma samples collection

## Key facts

- **NCT ID:** NCT03899389
- **Lead sponsor:** Gdansk University of Physical Education and Sport
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-01
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2019-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03899389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03899389, "Plasma TMAO (Trimethylamine N-oxide) as a Predictive Marker in Coronary Disease Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03899389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*